Phase II study of imatinib in patients with small cell lung cancer.
Johnson BE, Fischer T, Fischer B, Dunlop D, Rischin D, Silberman S, Kowalski MO, Sayles D, Dimitrijevic S, Fletcher C, Hornick J, Salgia R, Le Chevalier T.
Johnson BE, et al.
Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5880-7.
Clin Cancer Res. 2003.
PMID: 14676110
Clinical Trial.